I love the confidence in the board on the future success of the 5 path trials that increasing the value of RAC through NPP is no longer a consideration, and instead are happy to provide Bisantrene on compassionate use.
Absolutely unreal and great morals shown in the leaders of the company.
IMO, etc...
General Comments / Chat, page-177
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
-0.065(4.19%) |
Mkt cap ! $254.2M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.56 | $1.49 | $64.17K | 42.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 670 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 544 | 1 |
View Market Depth
| Last trade - 12.22pm 20/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.48 |
Change
-0.065 ( 2.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.57 | $1.57 | $1.48 | 3489 | ||
| Last updated 12.49pm 20/05/2024 ? | |||||
| RAC (ASX) Chart |